Angiocrine Bioscience CEO and key executive team

Angiocrine Bioscience's Chairman & Co-Founder is Jeffrey L. Port. Angiocrine Bioscience's key executives include Jeffrey L. Port and 13 others.
Jeffrey L. Port

Jeffrey L. Port

Chairman & Co-Founder
Edward Kavalerchik

Edward Kavalerchik

Executive Medical Director, Clinical Development
Andrew I. Brooks

Andrew I. Brooks

Director
Lee Landeen

Lee Landeen

Executive Director, Pre-Clinical Development
John R. Jaskowiak

John R. Jaskowiak

Chief Operating Officer
Paul Finnegan

Paul Finnegan

Chief Executive Officer
Ronda Schreiber

Ronda Schreiber

Senior Director, Technical Operations
John K. Fraser

John K. Fraser

Chief Scientific Officer
Jeff Jonas

Jeff Jonas

Director
Michael Ginsberg

Michael Ginsberg

Senior Director, Product Development
Margie Breneman

Margie Breneman

Senior Director, Project Management
David R. Parkinson

David R. Parkinson

Director
Daniel J. Nolan

Daniel J. Nolan

Director, External Research
Gayle Bresnahan

Gayle Bresnahan

Director, Clinical Operations
Last updated: